IRIS CTO: Chronic Total Occlusion Registry

Sponsor
Seung-Jung Park (Other)
Overall Status
Terminated
CT.gov ID
NCT04041921
Collaborator
CardioVascular Research Foundation, Korea (Other)
4,006
19
147.2
210.8
1.4

Study Details

Study Description

Brief Summary

This study evaluated the long-term outcome of patients with chronic total occlusion treated with percutaneous coronary intervention, medical treatment or coronary artery bypass grafting.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Percutaneous coronary intervention
  • Procedure: Coronary Artery Bypass Grafting
  • Drug: Medical treatment

Detailed Description

This study is connected with Decision-CTO trial(NCT01078051). Randomized subjects and registry group subjects from Decision-CTO trial continue 10 years follow-up on this study.

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
4006 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
A Multicenter, Prospective, Real World Observational Study for Chronic Total Occlusion
Actual Study Start Date :
Jan 1, 2010
Actual Primary Completion Date :
Apr 8, 2022
Actual Study Completion Date :
Apr 8, 2022

Arms and Interventions

Arm Intervention/Treatment
Chronic coronary occlusion patients

≥3 months chronic total occlusion on coronary angiography

Procedure: Percutaneous coronary intervention

Procedure: Coronary Artery Bypass Grafting

Drug: Medical treatment

Outcome Measures

Primary Outcome Measures

  1. Composite event of all cause death, myocardial infarction, stroke or all kinds of repeat revascularization [10 years]

Secondary Outcome Measures

  1. Event rate of all cause death [10 years]

  2. Event rate of acute myocardial infarction [10 years]

  3. Event rate of stroke [10 years]

  4. Event rate of repeat revascularization [10 years]

  5. Event rate of rehospitalization due to acute coronary syndrome [10 years]

  6. The rate change of left ventricular ejection fraction [10 years]

  7. Composite event of death, myocardial, stroke or repeat revascularization [5 years]

  8. Composite event of death, myocardial, stroke or repeat revascularization [10 years]

  9. Event rate of Procedural success [5 days]

    Procedural success is defined as < 30% final stenosis and the absence of in-hospital event including death, Q-wave myocardial infarction or urgent repeat revascularization.

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with angina or silent ischemia and documented ischemia

  • Patients with De novo chronic coronary occlusion ≥ 3months and reference diameter ≥ 2.5 mm on coronary angiography

  • Age > 18 years

Exclusion Criteria:
  • Refuse to participate in this study

Contacts and Locations

Locations

Site City State Country Postal Code
1 SAM hospital Anyang Korea, Republic of
2 Soon Chun Hyang University Hospital Bucheon Bucheon Korea, Republic of
3 Soon Chun Hyang University Hospital Cheonan Cheonan Korea, Republic of
4 Chungbuk National University Hospital Cheongju Korea, Republic of
5 Gangwon National Univ. Hospital Chuncheon Korea, Republic of
6 Keimyung University Dongsan Medical Center Daegu Korea, Republic of
7 Chungnam National University Hospital Daejeon Korea, Republic of
8 The Catholic University of Korea, Daejeon ST. Mary's Hospital Daejeon Korea, Republic of
9 Gangneung Asan Hospital Gangneung Korea, Republic of
10 Chonnam National University Hospital Gwangju Korea, Republic of
11 ChonBuk National University Hospital Jeonju Korea, Republic of
12 Dong-A Medical Center Pusan Korea, Republic of
13 Pusan National University Yangsan Hospital Pusan Korea, Republic of
14 Bundang CHA Hospital Seongnam Korea, Republic of
15 Asan Medical Hospital Seoul Korea, Republic of
16 Korea University Guro Hospital Seoul Korea, Republic of
17 The Catholic University of Korea Seoul St. Mary's Hospital Seoul Korea, Republic of
18 Ulsan University Hospital Ulsan Korea, Republic of
19 Wonju Severance Christian Hospital Wonju Korea, Republic of

Sponsors and Collaborators

  • Seung-Jung Park
  • CardioVascular Research Foundation, Korea

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Seung-Jung Park, Professor,University of Ulsan College of Medicine, Asan Medical Center
ClinicalTrials.gov Identifier:
NCT04041921
Other Study ID Numbers:
  • CVRF2009-06
First Posted:
Aug 1, 2019
Last Update Posted:
Apr 18, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Seung-Jung Park, Professor,University of Ulsan College of Medicine, Asan Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 18, 2022